Intellia demonstrates efficacy of gene therapy in preclinical models

By The Science Advisory Board staff writers

December 14, 2020 -- Intellia Therapeutics has demonstrated that physiological protein levels of human alpha-1 antitrypsin (AAT) in nonhuman primates can be achieved following a single administration of its in vivo gene therapy.

In the nonhuman primate study, the company achieved normal AAT protein levels following targeted insertion of the human SERPINA1 gene, which remained stable through at least 11 weeks.

The SERPINA1 gene normally encodes the AAT protein produced in the liver that is then secreted to protect the lungs. SERPINA1 mutations can cause AAT deficiency, a rare, genetic disease that commonly manifests in lung dysfunction, as well as in liver disease in some patients.

The company is developing several CRISPR/Cas9-based genome editing strategies to treat lung and liver manifestations of AAT deficiencies, which occur due to mutations in the SERPINA1 gene. Intellia's targeted in vivo insertion platform uses a hybrid delivery system combining a nonviral lipid nanoparticle, which encapsulates CRISPR/Cas9 components, with an adeno-associated virus carrying a donor DNA template to enable therapeutic protein production.

The company is also investigating a consecutive genome editing approach where the PiZ allele – the most common disease-causing mutation of SERPINA1 -- is knocked out and the normal human SERPINA1 gene is inserted.

Intellia to advance CRISPR treatment for sickle cell
Intellia Therapeutics has received a grant from the Bill & Melinda Gates Foundation to research in vivo sickle cell disease treatments using its CRISPR/Cas9...
Regeneron, Intellia to develop CRISPR/Cas9-based treatments
Regeneron Pharmaceuticals and Intellia Therapeutics have expanded their existing collaboration to provide Regeneron with rights to develop in vivo CRISPR/Cas9-based...
CRISPR - A New Era in Genome Editing
A major buzzword in the science world recently has been CRISPR: short for Clustered Regularly Interspaced Short Palindromic Repeats. This is a simple,...

Copyright © 2020 scienceboard.net


Conferences
International Society for Cell and Gene Therapy Annual Meeting
May 4 - June 7
San Francisco, California United States
Interphex 2022 Conference
May 24-26
New York, New York United States
American Society for Mass Spectrometry Annual Conference
June 5-9
Minneapolis, Minnesota United States
American Society for Microbiology Microbe Meeting
June 9-13
District of Columbia United States
HPLC 2022
June 18-23
San Diego, California United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter